查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1495991

胎儿和新生儿护理设备市场：2024-2029年预测

Fetal & Neonatal Care Equipment Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 139 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球胎儿和新生儿护理设备市场的复合年增长率为6.48%，从2022年的98.09亿美元增加到2029年底的152.27亿美元。

胎儿和新生儿护理设备为诊断患有疾病的新生儿和胎儿提供护理，无论是出于监测、治疗还是诊断目的。这些设备包括照光治疗设备、培养箱、心肺监视器、脐导管、脉动式血氧监测仪系统等。

由于全球早产率不断上升，预计该市场将快速成长。先天性疾病的增加进一步增加了预测期内的市场需求。技术进步带来的先进系统的可用性是未来五年进一步推动市场成长的驱动力。

此外，不孕症旅游的扩张需要最先进的设备来监测胎儿和新生儿的健康状况，这进一步为预测期内的市场扩张提供了机会。对 35 岁及以上母亲怀孕和分娩期间併发症风险增加的担忧也将在预测期内扩大市场。

市场驱动因素：

  • 生育旅游热度持续扩大市场

生育旅游，也称为跨境生殖保健（CBRC），在全球范围内越来越受欢迎，因为不孕夫妇和人们（包括单身人士、同性恋者和跨性别者）在本国以外寻求有效的生育治疗。采用海外生殖医学的主要原因包括本国的法律法规和高昂的治疗费用。

除其他原因外，治疗质量，即成功率、漫长的等待时间和社会文化因素在选择国外不孕症治疗时起着重要作用。最常见的不孕症治疗包括体外受精、显微授精、捐赠精子、捐赠卵子和保留生育能力。

世界各地男性和女性不孕症发病率的增加是推动生育旅游的主要因素之一。在美国，大约 10% 15 岁至 44 岁之间的女性难以怀孕或维持怀孕。在国际上，估计超过8%的夫妇有不孕问题。此外，根据分析，近50%的不孕症患者受男性影响。因此，随着生殖医学需求的增加，市场预计将显着成长。

男性不孕症是由某些疾病引起的，例如糖尿病、甲状腺疾病、遗传性疾病和荷尔蒙失衡。女性不孕不育的原因是不健康的生活方式，如吸烟、主动或被动、肥胖或超重、接触化学物质以及精神压力。

剖腹产手术的数量正在增加，为预测期内的市场成长提供了机会。

人们普遍注意到剖腹产率正在迅速增加。此外，据观察，在中国、东南欧和拉丁美洲国家等地区，剖腹产率超过了阴道分娩的数量。即使在低度开发国家，剖腹产率也相当高。例如，众所周知，在孟加拉国，不到 60% 的分娩是在诊所进行的，其中约 65% 是剖腹产。因此，剖腹产的增加为市场带来了巨大的成长机会。

全球和地区剖腹产率的增加是由于在医疗保健机构中分娩的比例不断增加，这是有原因的。此外，有人指出，在低收入和中等收入国家，剖腹产在最富有的人中比贫困阶级的人中更为普及。

此外，在低产科风险分娩中，剖腹产的使用率较高，尤其是在受过教育的女性中。例如，在巴西和中国，私人医疗机构进行剖腹产的可能性大约是公共医疗机构的 1.6 倍。作为剖腹产计划的一部分，剖腹产需要在分娩后持续监测胎儿和新生儿，这将进一步增加预测期内的市场需求。

作为剖腹产计划的一部分，剖腹产的采用需要对分娩后的胎儿和新生儿进行持续监测，从而增加了预测期内的市场需求。世界卫生组织建议的剖腹产率为10-15%。对于低风险女性，建议从目前约27-24%的年率降低。在美国，这一比例要高得多，约为 32%。

北美地区作为市场占有重要地位。

从地区来看，由于北美为母亲及其新生儿提供先进的医疗保健设施，预计在预测期内将占据很大的市场占有率。美国的医疗保健成本最高，进一步推动了预测期内市场的成长。从基于数量的医疗保健向基于价值的医疗保健的转变进一步增强了预测期内市场增长的前景。

主要进展

  • 2024 年 1 月：Butterfly Network 的新一代手持式超音波系统 Butterfly iQ3 获得 FDA 批准。该设备是世界上第一个基于半导体的单探头全身超音波系统的第三次迭代。 Butterfly iQ3将资料处理速度提高了一倍，以优化影像解析度、灵敏度和渗透性，并在自动影像捕捉模式下加速了3D功能。
  • 2023 年 11 月 - 皇家飞利浦获得比尔及梅琳达盖兹基金会的第二轮资金，以加速 Lumify 手持式超音波人工智慧演算法的全球普及。该技术简化了妊娠异常的识别，并将训练时间从几週缩短到几小时。这笔资金将支持将人工智慧辅助工具部署到世界服务不足的地区。 Lumify 手持式超音波是首款商业性推出的照护现场超音波设备，可自动撷取并解释产科测量的影像。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关利益者的主要利益

第二章调查方法

  • 研究设计
  • 调查过程

第三章执行摘要

  • 主要发现

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第五章胎儿和新生儿护理设备市场：按类型

  • 介绍
  • 胎儿护理
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 新生儿护理
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力

第六章胎儿和新生儿护理设备市场：副产品

  • 介绍
  • 监视器
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 治疗设备
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 诊断设备
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力

第七章胎儿和新生儿护理设备市场：按最终用户分类

  • 介绍
  • 医院
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 诊所
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 研究中心
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力

第八章胎儿和新生儿护理设备市场：按地区

  • 介绍
  • 北美洲
    • 按类型
    • 副产品
    • 按最终用户
    • 按国家/地区
  • 南美洲
    • 按类型
    • 副产品
    • 按最终用户
    • 按国家/地区
  • 欧洲
    • 按类型
    • 副产品
    • 按最终用户
    • 按国家/地区
  • 中东/非洲
    • 按类型
    • 副产品
    • 按最终用户
    • 按国家/地区
  • 亚太地区
    • 按类型
    • 副产品
    • 按最终用户
    • 按国家/地区

第九章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第十章 公司简介

  • Aspect Imaging Ltd.
  • General Electric Company
  • EMCO Meditek Pvt. Ltd.
  • Fisher & Paykel Healthcare Limited
  • Masimo Corporation
  • Natus Medical Incorporated
  • Phoenix Medical Systems（P）Ltd.
  • Dragerwerk AG & Co. KGaA
  • Spacelabs Healthcare（OSI Systems, Inc.）
  • Becton, Dickinson and Company
简介目录
Product Code: KSI061611882

The global fetal & neonatal care equipment market is evaluated to surge at a CAGR of 6.48% from a market value of USD9.809 billion in 2022 to reach USD15.227 billion by the end of 2029.

Fetal & neonatal care equipment, whether for monitoring, treatment, or diagnostic purposes, offers care to a newborn or an unborn fetus diagnosed with a medical condition. These pieces of equipment comprise phototherapy equipment, incubators, cardiopulmonary monitors, umbilical catheters, pulse oximeters, and many more.

The market is projected to grow at a fast pace with the growing preterm birth rates at the global level. The growing incidences of congenital diseases are further augmenting the market demand during the forecast period. The availability of advanced systems due to technological advancements is further providing an impetus to fuel the market growth over the next five years.

Additionally, growing fertility tourism demands state-of-the-art equipment for monitoring fetal and newborn health, further providing an opportunity for the market to propagate during the forecast period. Concerns about the increased risk of complications during pregnancy and delivery for mothers over the age of 35 also expand the market during the forecast period.

Market Drivers:

  • The growing popularity of fertility tourism will continue to proliferate the market

Fertility tourism, also known as cross-border reproductive care (CBRC), is gaining popularity at the global level, where people, including infertile couples and single, gay, or transgender individuals, are seeking effective fertility treatments outside of their home countries. The major reasons for the adoption of reproductive treatments abroad include legal restrictions and the high cost of treatment in their home countries.

Among other reasons, quality of care, i.e., success rate, long waits, and sociocultural considerations, play a significant role in choosing fertility treatments abroad. The most common forms of fertility treatments involve in vitro fertilization, intracytoplasmic sperm injection, sperm donation, egg donation, and fertility preservation, among others.

Growing infertility among males and females worldwide is one of the major factors driving fertility tourism. In the United States, it has been observed that around 10% of women aged between 15 and 44 years of age are experiencing difficulty in conceiving or staying pregnant. On an international level, it has been estimated that over 8% of couples are affected by fertility issues. It has been further analyzed that out of all the infertility cases, close to 50% of them are affecting males. Hence, with this, the market is projected to show strong prospects for growth along with a greater demand for reproductive care.

Infertility in males is due to specific medical conditions like diabetes, thyroid disorders, genetic disorders, and hormonal imbalances, among others. For females, infertility arises due to the adoption of unhealthy living conditions like smoking, being active or passive, being obese or overweight, exposure to chemicals, and mental stress, among others.

The rising number of cesarean sections provides an opportunity for the market to thrive during the forecast period.

It has been widely noted that the rate of C-sections is growing at a rapid pace. Furthermore, it has been observed that the rate of cesarean has exceeded the number of vaginal deliveries in the regions of China, Southeast Europe, and Latin American countries. Even in less-developed nations, the rate of C-sections is quite high. For instance, in Bangladesh, less than 60% of births are known to occur in clinics, and of those, around 65% are C-sections. Hence, the market is provided with considerable growth opportunities with rising cesarean deliveries.

The global and regional increase in the adoption of cesarean section is attributed to the growing proportion of births taking place in healthcare facilities, along with the increase in cesarean use in these health facilities. It was further noticed that cesarean section usage was more prevalent in the richest countries than the poorest in low-income and middle-income countries.

Furthermore, high C-section use was observed among individuals with low obstetric-risk births, particularly among educated females. For instance, in Brazil and China, C-sections were estimated to be around 1.6 times more frequently performed in a private healthcare setting than in a public healthcare setting. The adoption of C-sections will require constant monitoring of the fetus and the newborn after delivery as a part of the C-section planning, further augmenting the market demand in the forecast period.

The adoption of C-sections will necessitate continuous monitoring of the fetus and newborn after delivery as part of the C-section planning, which will increase market demand during the forecast period. The WHO proposed rate for C-sections is 10-15%. It has been recommended that the annual rate should decline in low-risk females from the current rate of around 27-24%. In the United States, the rate is much higher, at around 32%.

The North American region is accounted to hold a significant marketplace.

Geographically, North America is projected to hold a significant market share in the forecast period owing to the advanced healthcare facilities for mothers and their newborns. The highest health expenditure in the United States is further contributing to surging market growth in the forecast period. The shift from volume-based care to value-based care is further offering strong market growth prospects in the forecast period.

Key developments:

  • January 2024- Butterfly Network received FDA clearance for its next-generation handheld ultrasound system, Butterfly iQ3. This device is the third iteration of the world's first semiconductor-based single-probe, whole-body ultrasound system. Butterfly iQ3 offers double the data processing speed for optimized image resolution, sensitivity, and penetration, as well as faster 3D capabilities for automated image capture modes. The device is designed to make ultrasound more accessible and approachable than ever before, making it a turning point in digital ultrasound technology.
  • November 2023- Royal Philips secured a second round of funding from the Bill & Melinda Gates Foundation to accelerate the global adoption of AI algorithms on its Lumify Handheld Ultrasound. The technology simplifies pregnancy abnormality identification, reducing training time from weeks to just hours. The funding supports the deployment of the AI-assisted tool to underserved communities globally. The Lumify Handheld Ultrasound is the first point-of-care ultrasound device to be introduced commercially, automating image acquisition and interpretation for obstetrics measurements.

Market Segmentation:

By Type

  • Fetal Care
  • Neonatal Care

By Product

  • Monitors
  • Treatment Equipment
  • Diagnostic Equipment

By End-User

  • Hospitals
  • Clinics
  • Research Centers

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Others
  • Middle East and Africa
  • UAE
  • Israel
  • Saudi Arabia
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Thailand
  • Taiwan
  • Indonesia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. FETAL & NEONATAL CARE EQUIPMENT MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Fetal Care
    • 5.2.1. Market Opportunities and Trends
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. Neonatal Care
    • 5.3.1. Market Opportunities and Trends
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness

6. FETAL & NEONATAL CARE EQUIPMENT MARKET BY PRODUCT

  • 6.1. Introduction
  • 6.2. Monitors
    • 6.2.1. Market Opportunities and Trends
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Treatment Equipment
    • 6.3.1. Market Opportunities and Trends
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness
  • 6.4. Diagnostic Equipment
    • 6.4.1. Market Opportunities and Trends
    • 6.4.2. Growth Prospects
    • 6.4.3. Geographic Lucrativeness

7. FETAL & NEONATAL CARE EQUIPMENT MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
    • 7.2.1. Market Opportunities and Trends
    • 7.2.2. Growth Prospects
    • 7.2.3. Geographic Lucrativeness
  • 7.3. Clinics
    • 7.3.1. Market Opportunities and Trends
    • 7.3.2. Growth Prospects
    • 7.3.3. Geographic Lucrativeness
  • 7.4. Research Centers
    • 7.4.1. Market Opportunities and Trends
    • 7.4.2. Growth Prospects
    • 7.4.3. Geographic Lucrativeness

8. FETAL & NEONATAL CARE EQUIPMENT MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Type
    • 8.2.2. By Product
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. USA
        • 8.2.4.1.1. Market Opportunities and Trends
        • 8.2.4.1.2. Growth Prospects
      • 8.2.4.2. Canada
        • 8.2.4.2.1. Market Opportunities and Trends
        • 8.2.4.2.2. Growth Prospects
      • 8.2.4.3. Mexico
        • 8.2.4.3.1. Market Opportunities and Trends
        • 8.2.4.3.2. Growth Prospects
  • 8.3. South America
    • 8.3.1. By Type
    • 8.3.2. By Product
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
        • 8.3.4.1.1. Market Opportunities and Trends
        • 8.3.4.1.2. Growth Prospects
      • 8.3.4.2. Argentina
        • 8.3.4.2.1. Market Opportunities and Trends
        • 8.3.4.2.2. Growth Prospects
      • 8.3.4.3. Others
        • 8.3.4.3.1. Market Opportunities and Trends
        • 8.3.4.3.2. Growth Prospects
  • 8.4. Europe
    • 8.4.1. By Type
    • 8.4.2. By Product
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. UK
        • 8.4.4.1.1. Market Opportunities and Trends
        • 8.4.4.1.2. Growth Prospects
      • 8.4.4.2. Germany
        • 8.4.4.2.1. Market Opportunities and Trends
        • 8.4.4.2.2. Growth Prospects
      • 8.4.4.3. France
        • 8.4.4.3.1. Market Opportunities and Trends
        • 8.4.4.3.2. Growth Prospects
      • 8.4.4.4. Italy
        • 8.4.4.4.1. Market Opportunities and Trends
        • 8.4.4.4.2. Growth Prospects
      • 8.4.4.5. Others
        • 8.4.4.5.1. Market Opportunities and Trends
        • 8.4.4.5.2. Growth Prospects
  • 8.5. Middle East and Africa
    • 8.5.1. By Type
    • 8.5.2. By Product
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. UAE
        • 8.5.4.1.1. Market Opportunities and Trends
        • 8.5.4.1.2. Growth Prospects
      • 8.5.4.2. Israel
        • 8.5.4.2.1. Market Opportunities and Trends
        • 8.5.4.2.2. Growth Prospects
      • 8.5.4.3. Saudi Arabia
        • 8.5.4.3.1. Market Opportunities and Trends
        • 8.5.4.3.2. Growth Prospects
      • 8.5.4.4. Others
        • 8.5.4.4.1. Market Opportunities and Trends
        • 8.5.4.4.2. Growth Prospects
  • 8.6. Asia Pacific
    • 8.6.1. By Type
    • 8.6.2. By Product
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. Japan
        • 8.6.4.1.1. Market Opportunities and Trends
        • 8.6.4.1.2. Growth Prospects
      • 8.6.4.2. China
        • 8.6.4.2.1. Market Opportunities and Trends
        • 8.6.4.2.2. Growth Prospects
      • 8.6.4.3. India
        • 8.6.4.3.1. Market Opportunities and Trends
        • 8.6.4.3.2. Growth Prospects
      • 8.6.4.4. South Korea
        • 8.6.4.4.1. Market Opportunities and Trends
        • 8.6.4.4.2. Growth Prospects
      • 8.6.4.5. Thailand
        • 8.6.4.5.1. Market Opportunities and Trends
        • 8.6.4.5.2. Growth Prospects
      • 8.6.4.6. Taiwan
        • 8.6.4.6.1. Market Opportunities and Trends
        • 8.6.4.6.2. Growth Prospects
      • 8.6.4.7. Indonesia
        • 8.6.4.7.1. Market Opportunities and Trends
        • 8.6.4.7.2. Growth Prospects
      • 8.6.4.8. Others
        • 8.6.4.8.1. Market Opportunities and Trends
        • 8.6.4.8.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Aspect Imaging Ltd.
  • 10.2. General Electric Company
  • 10.3. EMCO Meditek Pvt. Ltd.
  • 10.4. Fisher & Paykel Healthcare Limited
  • 10.5. Masimo Corporation
  • 10.6. Natus Medical Incorporated
  • 10.7. Phoenix Medical Systems (P) Ltd.
  • 10.8. Dragerwerk AG & Co. KGaA
  • 10.9. Spacelabs Healthcare (OSI Systems, Inc.)
  • 10.10. Becton, Dickinson and Company